These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34453034)

  • 1. Cerebral μ-opioid and CB
    Kantonen T; Karjalainen T; Pekkarinen L; Isojärvi J; Kalliokoski K; Kaasinen V; Hirvonen J; Nuutila P; Nummenmaa L
    Transl Psychiatry; 2021 Aug; 11(1):442. PubMed ID: 34453034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB
    Kantonen T; Pekkarinen L; Karjalainen T; Bucci M; Kalliokoski K; Haaparanta-Solin M; Aarnio R; Dickens AM; von Eyken A; Laitinen K; Houttu N; Kirjavainen AK; Helin S; Hirvonen J; Rönnemaa T; Nuutila P; Nummenmaa L
    Int J Obes (Lond); 2022 Feb; 46(2):400-407. PubMed ID: 34728775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
    Seely KA; Brents LK; Franks LN; Rajasekaran M; Zimmerman SM; Fantegrossi WE; Prather PL
    Neuropharmacology; 2012 Oct; 63(5):905-15. PubMed ID: 22771770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain.
    Karlsson HK; Tuominen L; Tuulari JJ; Hirvonen J; Parkkola R; Helin S; Salminen P; Nuutila P; Nummenmaa L
    J Neurosci; 2015 Mar; 35(9):3959-65. PubMed ID: 25740524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food.
    Ward HG; Simansky KJ
    Psychopharmacology (Berl); 2006 Sep; 187(4):435-46. PubMed ID: 16847679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual variability and lateralization of μ-opioid receptors in the human brain.
    Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L
    Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal Variation in the Brain μ-Opioid Receptor Availability.
    Sun L; Tang J; Liljenbäck H; Honkaniemi A; Virta J; Isojärvi J; Karjalainen T; Kantonen T; Nuutila P; Hietala J; Kaasinen V; Kalliokoski K; Hirvonen J; Scheinin H; Helin S; Eerola K; Savontaus E; Yatkin E; Rinne JO; Roivainen A; Nummenmaa L
    J Neurosci; 2021 Feb; 41(6):1265-1273. PubMed ID: 33361461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain.
    Joutsa J; Karlsson HK; Majuri J; Nuutila P; Helin S; Kaasinen V; Nummenmaa L
    Psychiatry Res Neuroimaging; 2018 Jun; 276():41-45. PubMed ID: 29655552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. μ-opioid receptor system mediates reward processing in humans.
    Nummenmaa L; Saanijoki T; Tuominen L; Hirvonen J; Tuulari JJ; Nuutila P; Kalliokoski K
    Nat Commun; 2018 Apr; 9(1):1500. PubMed ID: 29662095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased consumption of sweet fluids in μ opioid receptor knockout mice: a microstructural analysis of licking behavior.
    Ostlund SB; Kosheleff A; Maidment NT; Murphy NP
    Psychopharmacology (Berl); 2013 Sep; 229(1):105-13. PubMed ID: 23568577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.
    Fattore L; Viganò D; Fadda P; Rubino T; Fratta W; Parolaro D
    Eur J Neurosci; 2007 Apr; 25(7):2191-200. PubMed ID: 17419755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.
    Saanijoki T; Nummenmaa L; Tuulari JJ; Tuominen L; Arponen E; Kalliokoski KK; Hirvonen J
    Hum Brain Mapp; 2018 Oct; 39(10):3972-3983. PubMed ID: 29885086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant mesolimbic dopamine-opiate interaction in obesity.
    Tuominen L; Tuulari J; Karlsson H; Hirvonen J; Helin S; Salminen P; Parkkola R; Hietala J; Nuutila P; Nummenmaa L
    Neuroimage; 2015 Nov; 122():80-6. PubMed ID: 26260431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.
    Burghardt PR; Rothberg AE; Dykhuis KE; Burant CF; Zubieta JK
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3193-201. PubMed ID: 26108093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety.
    Nummenmaa L; Karjalainen T; Isojärvi J; Kantonen T; Tuisku J; Kaasinen V; Joutsa J; Nuutila P; Kalliokoski K; Hirvonen J; Hietala J; Rinne J
    Neuropsychopharmacology; 2020 Oct; 45(11):1953-1959. PubMed ID: 32473595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic Fitness Is Associated with Cerebral μ-Opioid Receptor Activation in Healthy Humans.
    Saanijoki T; Kantonen T; Pekkarinen L; Kalliokoski K; Hirvonen J; Malén T; Tuominen L; Tuulari JJ; Arponen E; Nuutila P; Nummenmaa L
    Med Sci Sports Exerc; 2022 Jul; 54(7):1076-1084. PubMed ID: 35195103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study.
    Ceccarini J; Weltens N; Ly HG; Tack J; Van Oudenhove L; Van Laere K
    Transl Psychiatry; 2016 Jul; 6(7):e853. PubMed ID: 27404285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Neurochem Int; 2008 Jan; 52(1-2):321-8. PubMed ID: 17698254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mu-Opioid receptor stimulation in the nucleus accumbens elevates fatty tastant intake by increasing palatability and suppressing satiety signals.
    Katsuura Y; Heckmann JA; Taha SA
    Am J Physiol Regul Integr Comp Physiol; 2011 Jul; 301(1):R244-54. PubMed ID: 21543633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.